Transcriptomic Profiling and In Silico Drug Repurposing Reveal BIRC5 and AURKA as Actionable Targets in Triple-Negative Breast Cancer. Bangla J Med Phys. 2025;16(2):56-64. doi:10.3329/bjmp.v16i2.84807